
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Best Amusement Park in Asia: Which One Is a Must-Visit - 2
Which restaurants and fast food chains will be open on Christmas Eve and Christmas Day? - 3
The face is familiar, the name might not be. The king of "Hey, it's that guy!' roles is ready to show you his next act. - 4
What's your #1 tone - 5
US healthcare spending soars to over $5 trillion in 2024
6 Exemplary Mexican Dishes
Turkey's Erdogan denounces Israel-Greece-Cyprus trilateral summit, affirms support for Gaza
Favored Organic product for Seniors' Prosperity: Make Your Determination
What's changing about healthcare in 2026 — Medicare, Medicaid, ACA, premiums, and enrollment deadlines
A definitive Handbook for Securities exchange Money management
Paraplegic engineer becomes the first wheelchair user to blast into space
Vacuum Cleaners That Are Not difficult To Use For Home
BravoCon 2025: How to watch, full schedule and lineup, where to stream free and more
Genesis Marks 10th Anniversary With Magma GT Concept Aimed at High-Performance Flagships












